Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001227
UniProt IDP48637
Primary gene name(s)GSS
Synonym gene name(s)unknown
Protein nameGlutathione synthetase
Protein functionunknown
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P48637
Gene Ontology
(Biological Process)
Complete annatation
aging [GO:0007568];
cellular amino acid metabolic process [GO:0006520];
glutathione biosynthetic process [GO:0006750];
nervous system development [GO:0007399];
response to amino acid [GO:0043200];
response to cadmium ion [GO:0046686];
response to nutrient levels [GO:0031667];
response to oxidative stress [GO:0006979];
response to tumor necrosis factor [GO:0034612];
response to xenobiotic stimulus [GO:0009410]
Gene Ontology
(Molecular Function)
Complete annatation
ATP binding [GO:0005524];
glutathione binding [GO:0043295];
glutathione synthase activity [GO:0004363];
glycine binding [GO:0016594];
magnesium ion binding [GO:0000287];
protein homodimerization activity [GO:0042803]
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829];
extracellular exosome [GO:0070062]
Protein-protein interaction109192
Phylogenetic treeP48637
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.4416447585916010.1815099728330640.282908884760921
AZA vs. DISU-0.1962449340541540.4400717865220460.91814655876178
AZA vs. IL70.04904930032363220.8003210596699580.999311006273513
AZA vs. SAHA-0.2430477776239320.322287226664320.692933626406784
DISU vs. CD3-0.6510592171808850.07511014919210810.148935857527208
DISU vs. IL70.2359158112921340.3511822568618960.732180363653542
DISU vs. SAHA-0.0441808790783160.8799721872274460.96945856056033
DMSO vs. AZA0.02183338295006640.8975260202988851
DMSO vs. CD3-0.4337124215354080.1801347492747030.275362692960655
DMSO vs. DISU0.2155638586423920.3794946008662630.857061968710033
DMSO vs. IL70.03470977380611980.848385350659660.966739578515353
DMSO vs. SAHA-0.2696597835602710.255527994900250.604773145258343
HIV vs. Mock in Activation-0.05981593099225360.9235006823478570.999983755607037
HIV vs. Mock in Latency-0.1081147665324620.5180890968131310.999834320637052
IL7 vs. CD3-0.3862454692039390.2317503888396650.360976915467631
SAHA vs. CD3-0.7083673287158980.04838445185033250.0963260513439675
SAHA vs. IL7-0.2942037423694150.2305429277816110.471278016460537
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
0.5262 0.02516

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.0169876 0.940513
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.054 1.062 1.31 1.407 1.253
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB00145 Glycine approved, nutraceutical, vet_approved unknown unknown
DB00143 Glutathione approved, nutraceutical unknown unknown
DB03408 gamma-Glutamylcysteine experimental unknown unknown
DB04395 Phosphoaminophosphonic Acid-Adenylate Ester experimental unknown unknown
DB00151 L-Cysteine approved, nutraceutical unknown unknown
DB06151 Acetylcysteine approved yes stimulator

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
2HGS X-ray 2.1Å A=1-474.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Tat modulates 9501919
Tat inhibits 24480751

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00270 Cysteine and methionine metabolism - Homo sapiens (human)
hsa00480 Glutathione metabolism - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)